Physician profile
Travis L Bailey
NPI 1164711313
$7,346.33
in general payments reported to CMS, 2019-2025
28 companies · $382 in 2025
The $382 reported for 2025 was less than what a typical Pain Medicine provider received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $756 · 2020: $1,047 · 2021: $825 · 2022: $2,948 · 2023: $771 · 2024: $618 · 2025: $382.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,685 · Travel and Lodging: $85.94.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,684.58 |
| Travel and Lodging | $85.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $2,859.45 | 2019-2024 | Senza |
| Spinal Simplicity, LLC | $1,969.16 | 2022-2025 | Ha Minuteman G3-R |
| Vertos Medical, INC. | $552.31 | 2022-2023 | Mild Device Kit |
| Painteq LLC | $436.59 | 2022-2024 | Painteq |
| Boston Scientific Corporation | $356.99 | 2020-2023 | Wavewriter Alpha Prime 16 |
| Abbott Laboratories | $247.10 | 2019-2025 | Proclaim, Eterna |
| Almatica Pharma LLC | $138.51 | 2021-2023 | Gralise |
| Radius Health, INC. | $119.31 | 2019-2021 | |
| Medtronic, INC. | $89.40 | 2021-2025 | Intellis Adaptivestim, Inceptiv |
| Biotronik Nro, INC. | $82.43 | 2025 | Prospera |
| Globus Medical, INC. | $75.00 | 2025 | Senza |
| Mml US, INC. | $72.57 | 2025 | Reactiv8 |
| Medtronic USA, INC. | $34.66 | 2019 | |
| Collegium Pharmaceutical, INC. | $29.94 | 2019-2022 | |
| Pfizer INC. | $29.54 | 2020 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biodelivery Sciences International, INC. | $28.83 | 2019-2021 | |
| Zimmer Biomet Holdings, INC. | $25.00 | 2019 | |
| Flowonix Medical Incorporated | $22.66 | 2020 | |
| Novartis Pharmaceuticals Corporation | $21.35 | 2020 | |
| Forte Bio-Pharma LLC | $21.32 | 2020 | |
| Vericel Corporation | $19.99 | 2019 | |
| Nalu Medical, INC. | $19.65 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $18.62 | 2025 | |
| Bioventus LLC | $16.54 | 2019 | |
| Amgen INC. | $16.15 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.80 | 2022 | |
| Scilex Pharmaceuticals INC. | $14.57 | 2023 | Ztlido |
| Kowa Pharmaceuticals America, INC. | $13.89 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Travis Bailey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.